Erica Lenton
Dados Biográficos
| ID | 198560 |
|---|---|
| NOME | Erica Lenton |
| PRENOMES | Erica |
| SOBRENOME | Lenton |
| ASSINATURA | LENTON E |
| AFILIAÇÕES | La Trobe University |
| ORCID | 0000-0002-4465-2604 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 16 |
| TOTAL DE CITAÇÕES | 22 |
| TOTAL COMO AUTOR | 16 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2010 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 3 |
Performing Hepatitis C, Problematising “Cure”
Direct-acting antiviral (DAA) treatment for the blood-borne virus hepatitis C has shifted conceptions of the disease from a chronic infection – and, in some legal contexts, a “disability” – towards a non-permanent impairment capable of “cure”. The shift in treatment has also led to a shift in law. This paper explores the shift in Australian social security and migration judgments by drawing from performance studies research on disability and reco…
Stigmatising space-times
Stigma related to blood-borne viruses (BBVs) and sexually transmitted infections (STIs) has been shown to undermine the quality of healthcare. Given the pervasiveness and multiple manifestations of stigma within healthcare settings, recent research has argued that stigma should be addressed 'universally' i.e. for all stigmatising attributes and conditions, across all healthcare services. As part of the development of a universal approach to stigm…
Health-Related Stigma
Encounters with stigma in healthcare settings are well-documented. In recent years, significant attention has begun to be paid to how we can reduce these stigmas, including through the identification and reformation of structural forces that shape and sustain them. This article analyses 30 interviews conducted with clinical and nonclinical healthcare workers, as part of a larger project that aims to reduce health-related stigma for all. A major t…
We've got a present for you
With the advent of highly effective and tolerable direct-acting antiviral treatments for hepatitis C, widespread optimism for and investment in the project of disease elimination now informs the public health response. In Australia, the Commonwealth government has invested heavily in elimination by universally subsidising treatment, promising access for all. Reflecting concerns that commonly accompany ambitious public health projects, cost for go…
Troubling complaint
The need to grapple with hepatitis C-related stigma and discrimination in Australian health-care settings has been recognised in public policy, and work is underway to address it. But how likely are people to raise a complaint when they experience stigma or discrimination? And how effective and accessible are complaints mechanisms? Given complaint procedures are considered important parts of the delivery of safe and ethical health care, these are…
Hepatitis C data justice
The World Health Organization’s goal of achieving hepatitis C elimination by 2030 is inspiring the use of novel methods to find, diagnose and treat people living with the virus. Globally, rates of hepatitis C treatment uptake have declined. Data-driven public health approaches, including case finding, notification and contact tracing, are being developed and implemented to reach the elimination goal. Drawing on interviews with policymakers, lawye…
I’m not hep C free’
Since the advent of more effective, new-generation treatment for hepatitis C, immense resources have been devoted to delivering cure to as many people with the virus as possible. The scale-up of treatment aims to prevent liver disease, liver cancer and onward transmission of hepatitis C, but social research shows that people also approach treatment with its social promises in mind, including the hope that it might reduce or eradicate stigma from …
The trouble with normalisation
Modern health-care systems have customarily approached hepatitis C in ways that resemble the public health approach to HIV/AIDS known as 'HIV exceptionalism'. HIV exceptionalism describes the unusual emphasis on privacy, confidentiality and consent in approaches to HIV and was partly developed to address HIV/AIDS-related stigma. In the case of hepatitis C, exceptionalist approaches have included diagnosis and treatment by specialist physicians an…
Complicating cure
In recent years, highly tolerable and effective drugs have emerged promising a radical new 'post-hepatitis C' world. Optimism about medical cure potentially overlooks discrimination and stigma associated with hepatitis C and injecting drug use. Legal frameworks are especially relevant to hepatitis futures, since the law has the potential to reinforce or alleviate stigma and discrimination. This article explores how hepatitis C figures in Australi…
Echoes and Antibodies
New drugs with the potential to cure hepatitis C have emerged. There is great optimism within medicine about the transformative potential of cure, but this overlooks the entrenched discrimination and stigma associated with both hepatitis C and injecting drug use and the role of law in re/producing it. Drawing on interviews with key stakeholders such as policymakers, lawyers, and representatives from peer organisations (N = 30), Latour’s (2013) wo…
Becoming posthuman
Hepatitis C has long been a public health problem in Australia. ‘Revolutionary’ new drugs with the potential to cure hepatitis C have now emerged. The Australian government has invested heavily in them, and has an ambitious goal to eliminate hepatitis C by 2030. Numerous shifts in policy and practice are required if the elimination agenda is to be realised. This paper explores the significance of these shifts. We ask: what is the race to eliminat…
Maintaining the healthy body
Self-Management of Cardiac Pain in Women
Symptom recognition and self-management is instrumental in reducing the number of deaths related to coronary artery disease (CAD) in women. The purpose of this study was to synthesize qualitative research evidence on the self-management of cardiac pain and associated symptoms in women. Seven databases were systematically searched, and the concepts of the Individual and Family Self-Management Theory were used as the framework for data extraction a…
Hepatitis C health promotion and the anomalous sexual subject
Preventing hepatitis C virus transmission among young people in the justice system
Guilty or Angry? The Politics of Emotion in Accounts of Hepatitis C Transmission
In accounts of hepatitis C, subtle distinctions are frequently made between “innocent” and “guilty” forms of transmission. Although such distinctions have been extensively critiqued, they continue to manifest in indirect ways, such as the articulation of emotions. We argue for a critical approach to the way in which emotions function in accounts of hepatitis C by analyzing textual accounts of hepatitis C, and interviews with people who have hepat…
Becoming posthuman
Hepatitis C has long been a public health problem in Australia. ‘Revolutionary’ new drugs with the potential to cure hepatitis C have now emerged. The Australian government has invested heavily in them, and has an ambitious goal to eliminate hepatitis C by 2030. Numerous shifts in policy and practice are required if the elimination agenda is to be realised. This paper explores the significance of these shifts. We ask: what is the race to eliminat…
Complicating cure
In recent years, highly tolerable and effective drugs have emerged promising a radical new 'post-hepatitis C' world. Optimism about medical cure potentially overlooks discrimination and stigma associated with hepatitis C and injecting drug use. Legal frameworks are especially relevant to hepatitis futures, since the law has the potential to reinforce or alleviate stigma and discrimination. This article explores how hepatitis C figures in Australi…
The trouble with normalisation
Modern health-care systems have customarily approached hepatitis C in ways that resemble the public health approach to HIV/AIDS known as 'HIV exceptionalism'. HIV exceptionalism describes the unusual emphasis on privacy, confidentiality and consent in approaches to HIV and was partly developed to address HIV/AIDS-related stigma. In the case of hepatitis C, exceptionalist approaches have included diagnosis and treatment by specialist physicians an…
Troubling complaint
The need to grapple with hepatitis C-related stigma and discrimination in Australian health-care settings has been recognised in public policy, and work is underway to address it. But how likely are people to raise a complaint when they experience stigma or discrimination? And how effective and accessible are complaints mechanisms? Given complaint procedures are considered important parts of the delivery of safe and ethical health care, these are…
Echoes and Antibodies
New drugs with the potential to cure hepatitis C have emerged. There is great optimism within medicine about the transformative potential of cure, but this overlooks the entrenched discrimination and stigma associated with both hepatitis C and injecting drug use and the role of law in re/producing it. Drawing on interviews with key stakeholders such as policymakers, lawyers, and representatives from peer organisations (N = 30), Latour’s (2013) wo…
We've got a present for you
With the advent of highly effective and tolerable direct-acting antiviral treatments for hepatitis C, widespread optimism for and investment in the project of disease elimination now informs the public health response. In Australia, the Commonwealth government has invested heavily in elimination by universally subsidising treatment, promising access for all. Reflecting concerns that commonly accompany ambitious public health projects, cost for go…
Guilty or Angry? The Politics of Emotion in Accounts of Hepatitis C Transmission
In accounts of hepatitis C, subtle distinctions are frequently made between “innocent” and “guilty” forms of transmission. Although such distinctions have been extensively critiqued, they continue to manifest in indirect ways, such as the articulation of emotions. We argue for a critical approach to the way in which emotions function in accounts of hepatitis C by analyzing textual accounts of hepatitis C, and interviews with people who have hepat…
Guilty or Angry? The Politics of Emotion in Accounts of Hepatitis C Transmission
In accounts of hepatitis C, subtle distinctions are frequently made between “innocent” and “guilty” forms of transmission. Although such distinctions have been extensively critiqued, they continue to manifest in indirect ways, such as the articulation of emotions. We argue for a critical approach to the way in which emotions function in accounts of hepatitis C by analyzing textual accounts of hepatitis C, and interviews with people who have hepat…
Preventing hepatitis C virus transmission among young people in the justice system
Hepatitis C health promotion and the anomalous sexual subject
Self-Management of Cardiac Pain in Women
Symptom recognition and self-management is instrumental in reducing the number of deaths related to coronary artery disease (CAD) in women. The purpose of this study was to synthesize qualitative research evidence on the self-management of cardiac pain and associated symptoms in women. Seven databases were systematically searched, and the concepts of the Individual and Family Self-Management Theory were used as the framework for data extraction a…
Maintaining the healthy body
Becoming posthuman
Hepatitis C has long been a public health problem in Australia. ‘Revolutionary’ new drugs with the potential to cure hepatitis C have now emerged. The Australian government has invested heavily in them, and has an ambitious goal to eliminate hepatitis C by 2030. Numerous shifts in policy and practice are required if the elimination agenda is to be realised. This paper explores the significance of these shifts. We ask: what is the race to eliminat…
Echoes and Antibodies
New drugs with the potential to cure hepatitis C have emerged. There is great optimism within medicine about the transformative potential of cure, but this overlooks the entrenched discrimination and stigma associated with both hepatitis C and injecting drug use and the role of law in re/producing it. Drawing on interviews with key stakeholders such as policymakers, lawyers, and representatives from peer organisations (N = 30), Latour’s (2013) wo…
Hepatitis C data justice
The World Health Organization’s goal of achieving hepatitis C elimination by 2030 is inspiring the use of novel methods to find, diagnose and treat people living with the virus. Globally, rates of hepatitis C treatment uptake have declined. Data-driven public health approaches, including case finding, notification and contact tracing, are being developed and implemented to reach the elimination goal. Drawing on interviews with policymakers, lawye…
I’m not hep C free’
Since the advent of more effective, new-generation treatment for hepatitis C, immense resources have been devoted to delivering cure to as many people with the virus as possible. The scale-up of treatment aims to prevent liver disease, liver cancer and onward transmission of hepatitis C, but social research shows that people also approach treatment with its social promises in mind, including the hope that it might reduce or eradicate stigma from …
The trouble with normalisation
Modern health-care systems have customarily approached hepatitis C in ways that resemble the public health approach to HIV/AIDS known as 'HIV exceptionalism'. HIV exceptionalism describes the unusual emphasis on privacy, confidentiality and consent in approaches to HIV and was partly developed to address HIV/AIDS-related stigma. In the case of hepatitis C, exceptionalist approaches have included diagnosis and treatment by specialist physicians an…
Complicating cure
In recent years, highly tolerable and effective drugs have emerged promising a radical new 'post-hepatitis C' world. Optimism about medical cure potentially overlooks discrimination and stigma associated with hepatitis C and injecting drug use. Legal frameworks are especially relevant to hepatitis futures, since the law has the potential to reinforce or alleviate stigma and discrimination. This article explores how hepatitis C figures in Australi…
We've got a present for you
With the advent of highly effective and tolerable direct-acting antiviral treatments for hepatitis C, widespread optimism for and investment in the project of disease elimination now informs the public health response. In Australia, the Commonwealth government has invested heavily in elimination by universally subsidising treatment, promising access for all. Reflecting concerns that commonly accompany ambitious public health projects, cost for go…
Troubling complaint
The need to grapple with hepatitis C-related stigma and discrimination in Australian health-care settings has been recognised in public policy, and work is underway to address it. But how likely are people to raise a complaint when they experience stigma or discrimination? And how effective and accessible are complaints mechanisms? Given complaint procedures are considered important parts of the delivery of safe and ethical health care, these are…
Performing Hepatitis C, Problematising “Cure”
Direct-acting antiviral (DAA) treatment for the blood-borne virus hepatitis C has shifted conceptions of the disease from a chronic infection – and, in some legal contexts, a “disability” – towards a non-permanent impairment capable of “cure”. The shift in treatment has also led to a shift in law. This paper explores the shift in Australian social security and migration judgments by drawing from performance studies research on disability and reco…
Stigmatising space-times
Stigma related to blood-borne viruses (BBVs) and sexually transmitted infections (STIs) has been shown to undermine the quality of healthcare. Given the pervasiveness and multiple manifestations of stigma within healthcare settings, recent research has argued that stigma should be addressed 'universally' i.e. for all stigmatising attributes and conditions, across all healthcare services. As part of the development of a universal approach to stigm…
Health-Related Stigma
Encounters with stigma in healthcare settings are well-documented. In recent years, significant attention has begun to be paid to how we can reduce these stigmas, including through the identification and reformation of structural forces that shape and sustain them. This article analyses 30 interviews conducted with clinical and nonclinical healthcare workers, as part of a larger project that aims to reduce health-related stigma for all. A major t…
Medicine (13 obras) · Political science (13 obras) · Psychology (12 obras) · Psychiatry (10 obras) · Sociology (10 obras) · Law (9 obras) · Hepatitis C virus research (8 obras) · HIV, Drug Use, Sexual Risk (8 obras) · Social Psychology (7 obras) · Hepatitis C (6 obras)